Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K + channels

British Journal of Pharmacology

Volumn 159, Issue 3, 2010, Pages 669-677

  Szollosi, A ^a   Nenquin, M ^a   Henquin, J C ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Calcium channel blockers; Catecholamines; Congenital hyperinsulinism; Diabetes; Diphenylhydantoin; Imidazolines; Insulin secretion; Isolated islets; K ATP channels; Sulfonylurea receptor

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); ALINIDINE; ALPHA 2 ADRENERGIC RECEPTOR; CALCIUM; CLONIDINE; DIAZOXIDE; DOPAMINE; DOPAMINE RECEPTOR; EFAROXAN; GLUCOSE; INSULIN; ION CHANNEL; MEGLITINIDE; NIMODIPINE; PHENTOLAMINE; PHENYTOIN; PINACIDIL; QUININE; SULFONYLUREA DERIVATIVE; SULPHONYLUREA RECEPTOR 1; TETRYLAMMONIUM; TOLBUTAMIDE; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL STIMULATION; CELL TYPE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOSOL; DRUG BINDING SITE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN RELEASE; MOUSE; MUTATION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ANIMALS; BENZOFURANS; CALCIUM; CYTOSOL; DIAZOXIDE; FEMALE; IMIDAZOLES; IMIDAZOLINES; INSULIN; INSULIN-SECRETING CELLS; KATP CHANNELS; MICE; MICE, KNOCKOUT; PHENTOLAMINE; PINACIDIL; POTASSIUM CHANNELS; TOLBUTAMIDE;

EID: 76449109012     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00588.x     Document Type: Article

References (55)

1. Alexander SP, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edn. Br J Pharmacol 153 (Suppl. 2 S1 S209.
2. Aynsley-Green A, Hussain K, Hall J, Saudubray JM, Nihoul- Fékété C, De Lonlay-Debeney P et al. (2000). Practical management of hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed 82 : F98 F107.
3. + channels in mouse pancreatic beta-cells by external tetraethylammonium and quinine. J Physiol 423 : 327 342. (Pubitemid 20137761)
4. Bryan J, Crane A, Vila-Carriles WH, Babenko AP, Aguilar-Bryan L (2005). Insulin secretagogues, sulfonylurea receptors and K(ATP) channels. Curr Pharm Des 11 : 2699 2716.
5. + channels. Pflugers Arch 453 : 703 718.
6. Doyle ME, Egan JM (2003). Pharmacological agents that directly modulate insulin secretion. Pharmacol Rev 55 : 105 131.
7. + permeability of the β-cell membrane. Endocrinology 126 : 1646 1653.
8. 2+ concentration in SUR1(-/-) beta cells. Diabetologia 47 : 488 498.
9. Dunne MJ, Cosgrove KE, Shepherd RM, Aynsley-Green A, Lindley KJ (2004). Hyperinsulinism in infancy: from basic science to clinical disease. Physiol Rev 84 : 239 275.
10. ATP channel function. Biochem Biophys Res Commun 284 : 918 922.
11. Efendic S, Efanov AM, Berggren PO, Zaitsev SV (2002). Two generations of insulinotropic imidazoline compounds. Diabetes 51 (Suppl. 3 S448 S454.
12. Farret A, Lugo-Garcia L, Galtier F, Gross R, Petit P (2005). Pharmacological interventions that directly stimulate or modulate insulin secretion from pancreatic beta-cell: implications for the treatment of type 2 diabetes. Fundam Clin Pharmacol 19 : 647 656.
13. + channels in mouse pancreatic beta-cells. Br J Pharmacol 98 : 957 965.
14. Garrino MG, Schmeer W, Nenquin M, Meissner HP, Henquin JC (1985). Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide. Diabetologia 28 : 697 703.
15. ATP channels. Am J Physiol Endocrinol Metab 293 : E293 E301.
16. Ghaly H, Kriete C, Sahin S, Pflöger A, Holzgrabe U, Zünkler BJ et al. (2009). The insulinotropic effect of fluoroquinolones. Biochem Pharmacol 77 : 1040 1052.
17. ATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes. J Clin Invest 119 : 80 90.
18. + channels contributes to rhythmic firing of action potentials in mouse pancreatic beta cells. J Gen Physiol 114 : 759 770.
19. Gribble FM, Davis TME, Higham CE, Clark A, Ashcroft FM (2000). The antimalarial agent mefloquine inhibits ATP-sensitive K-channels. Br J Pharmacol 131 : 756 760.
20. Gribble FM, Reimann F (2003). Sulphonylurea action revisited: the post. cloning era. Diabetologia 46 : 875 891.
21. Grimmsmann T, Rustenbeck I (1998). Direct effects of diazoxide on mitochondria in pancreatic B-cells and on isolated liver mitochondria. Br J Pharmacol 123 : 781 788.
22. -/- mice. Diabetologia 48 : 913 921.
23. Henquin JC (1982). Quinine and the stimulus-secretion coupling in pancreatic beta-cells: glucose-like effects on potassium permeability and insulin release. Endocrinology 110 : 1325 1332.
24. + channels in the control of glucose-induced electrical activity in pancreatic B-cells. Pflügers Archiv 416 : 568 572.
25. Henquin JC (2004). Pathways in beta-cell stimulus-secretion coupling as targets for therapeutic insulin secretagogues. Diabetes 53 (Suppl. 3 S48 S58.
26. Henquin JC (2009). Regulation of insulin secretion: a matter of phase control and amplitude modulation. Diabetologia 52 : 739 751.
27. 2+ and amplification signals in beta-cells. Diabetes 55 : 441 451.
28. Herchuelz A, Lebrun P, Sener A, Malaisse WJ (1981). Ionic mechanism of diphenylhydantoin action on glucose-induced insulin release. Eur J Pharmacol 73 : 189 197.
29. Imanaka S, Matsuda S, Ito K, Matsuoka T, Okada Y (1986). Medical treatment for inoperable insulinoma: clinical usefulness of diphenylhydantoin and diltiazem. Jpn J Clin Oncol 16 : 65 71.
30. + channel. J Biol Chem 271 : 24321 24324.
31. Jacobson DA, Philipson LH (2007). Action potentials and insulin secretion: new insights into the role of Kv channels. Diabetes Obes Metab 9 (Suppl. 2 89 98.
32. + channels in pancreatic beta-cells. Br J Pharmacol 107 : 8 14.
33. 2+-induced insulin secretion from electrically permeabilised islets of Langerhans. FEBS Lett 219 : 139 144.
34. Lebrun P, Devreux V, Hermann M, Herchuelz A (1989). Similarities between the effects of pinacidil and diazoxide on ionic and secretory events in rat pancreatic islets. J Pharmacol Exp Ther 250 : 1011 1018.
35. + channels in insulin-secreting cells from rats. Diabetologia 40 : 1403 1410.
36. Levin SR, Grodsky GM, Hagura R, Smith D (1972). Comparison of the inhibitory effects of diphenylhydantoin and diazoxide upon insulin secretion from the isolated perfused pancreas. Diabetes 21 : 856 862.
37. + channels in pancreatic beta cells: role, regulation and potential as therapeutic targets. Diabetologia 46 : 1046 1062.
38. + channel in insulin-secreting pancreatic beta-cells. J Mol Endocrinol 22 : 113 123.
39. Moreau C, Prost AL, Derand R, Vivaudou M (2005). SUR, ABC proteins targeted by KATP channel openers. J Mol Cell Cardiol 38 : 951 963.
40. Morgan NG, Chan SL (2001). Imidazoline binding sites in the endocrine pancreas: can they fulfill their potential as targets for the development of new insulin secretagogues? Curr Pharm Des 7 : 1413 1431.
41. + concentration in pancreatic islets. Endocrinology 147 : 2717 2727.
42. Nenquin M, Szollosi A, Aguilar-Bryan L, Bryan J, Henquin JC (2004). Both triggering and amplifying pathways contribute to fuel-induced insulin secretion in the absence of sulfonylurea receptor-1 in pancreatic beta-cells. J Biol Chem 279 : 32316 32324.
43. Panten U, Burgfeld J, Goerke F, Rennicke M, Schwanstecher M, Wallasch A et al. (1989). Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Biochem Pharmacol 38 : 1217 1229.
44. ATP channels is mediated by Kir6.2. Proc Natl Acad Sci USA 94 : 11716 11720.
45. + channels. Role in stimulus-secretion coupling. J Biol Chem 271 : 32241 32246.
46. Rubí B, Ljubicic S, Pournourmohammadi S, Carobbio S, Armanet M, Bartley C et al. (2005). Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. J Biol Chem 280 : 36824 36832.
47. Sandström PE (1993). Inhibition by hydrochlorothiazide of insulin release and calcium influx in mouse pancreatic β-cells. Br J Pharmacol 110 : 1359 1362.
48. + channels. Eur J Pharmacol 497 : 111 117.
49. ATP channel-independent regulation of insulin secretion. J Biol Chem 275 : 9270 9277.
50. Sempoux C, Guiot Y, Dahan K, Moulin P, Stevens M, Lambot V et al. (2003). The focal form of persistent hyperinsulinemic hypoglycemia of infancy: morphological and molecular studies show structural and functional differences with insulinoma. Diabetes 52 : 784 794.
51. ATP channels. Am J Physiol Endocrinol Metab 286 : E463 E471.
52. 2+ signal. J Biol Chem 282 : 14768 14776.
53. 2+ and insulin release. Mol Pharmacol 28 : 100 106.
54. Zhang M, Houamed K, Kupershmidt S, Roden D, Satin LS (2005). Pharmacological properties and functional role of Kslow current in mouse pancreatic beta-cells: SK channels contribute to Kslow tail current and modulate insulin secretion. J Gen Physiol 126 : 353 363.
55. + channels. Life Sci 73 : 429 435.